Karen Jaqueline Low

Karen Jaqueline Low

Auto-generated profile, based on publicly available information

Karen Jaqueline Low

Centre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
KLKaren Low
Karen Low
TATazeen Ashraf
Tazeen Ashraf
NCNatalie Canham
Natalie Canham
JCJill Clayton‐Smith
Jill Clayton‐Smith
CDCharu Deshpande
Charu Deshpande
SSSarah Smithson
Sarah Smithson
KBG syndrome is characterized by short stature, distinctive facial features, and developmental/cognitive delay and is caused by mutations in ANKRD11, one of the ankyrin repeat‐containing cofactors. We describe 32 KBG patients aged 2–47 years from 27 families ascertained via two pathways: targeted ANKRD11 sequencing (TS) in a group who had a clinical diagnosis of KBG and whole exome sequencing (ES) in a second group in whom the diagnosis was unknown. Speech delay and learning difficulties were almost universal and variable behavioral problems frequent. Macrodontia of permanent upper central incisors was seen in 85%. Other clinical features included short stature, conductive hearing loss, recurrent middle ear infection, palatal abnormalities, and feeding difficulties. We recognized a new feature of a wide anterior fontanelle with delayed closure in 22%. The subtle facial features of KBG syndrome were recognizable in half the patients. We identified 20 ANKRD11 mutations (18 novel: all truncating) confirmed by Sanger sequencing in 32 patients. Comparison of the two ascertainment groups demonstrated that facial/other typical features were more subtle in the ES group. There were no conclusive phenotype–genotype correlations. Our findings suggest that mutation of ANKRD11 is a common Mendelian cause of developmental delay. Affected patients may not show the characteristic KBG phenotype and the diagnosis is therefore easily missed. We propose updated diagnostic criteria/clinical recommendations for KBG syndrome and suggest that inclusion of ANKRD11 will increase the utility of gene panels designed to investigate developmental delay. © 2016 The Authors. American Journal of Medical Genetics Part A Published by Wiley Periodicals, Inc.

1 February 2019 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
KLKaren J. Low
Karen J. Low
JBJ. Baptista
J. Baptista
MBM. Babiker
M. Babiker
RCR. Caswell
R. Caswell
CKC. King
C. King
ISI. Scurr
I. Scurr

3 July 2021 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
SOStephanie Oates
Stephanie Oates
MAMichael Absoud
Michael Absoud
SGSushma Goyal
Sushma Goyal
SBSophie Bayley
Sophie Bayley
JBJennifer Baulcomb
Jennifer Baulcomb
DPDeb K. Pal
Deb K. Pal

5 May 2014 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
KLK.J. Low
K.J. Low
ATA.R. Turnbull
A.R. Turnbull
KSK.R. Smith
K.R. Smith
THT.N. Hilliard
T.N. Hilliard
LHL.J. Hole
L.J. Hole
ADA. Donaldson
A. Donaldson

11 June 2023 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
HGH. Grimes
H. Grimes
MAM. Ansari
M. Ansari
TAT. Ashraf
T. Ashraf
ACAnna Mª. Cueto‐González
Anna Mª. Cueto‐González
ACA. Calder
A. Calder
KLKaren J. Low
Karen J. Low

29 January 2023 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
AHAsma Hamad
Asma Hamad
CSCharlotte Sherlaw-Sturrock
Charlotte Sherlaw-Sturrock
KGKate Glover
Kate Glover
RSRachel Salmon
Rachel Salmon
KLKaren Low
Karen Low
SNSwati Naik
Swati Naik